|
[1]
|
Lugano, R., Ramachandran, M. and Dimberg, A. (2020) Tumor Angiogenesis: Causes, Consequences, Challenges and Opportunities. Cellular and Molecular Life Sciences, 77, 1745-1770. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Montemagno, C. and Pagès, G. (2020) Resistance to An-ti-Angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs. Frontiers in Cell and Devel-opmental Biology, 8, Article 584. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Yang, T., Xiao, H., Liu, X., et al. (2021) Vascular Normalization: A New Window Opened for Cancer Therapies. Frontiers in Oncology, 11, Article 719836. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Viallard, C. and Larrivée, B. (2017) Tumor Angiogenesis and Vas-cular Normalization: Alternative Therapeutic Targets. Angiogenesis, 20, 409-426. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Roma-Rodrigues, C., Mendes, R., Baptista, P.V. and Fernandes, A.R. (2019) Targeting Tumor Microenvironment for Cancer Therapy. International Journal of Molecular Sciences, 20, Article No. 840. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Jena, BC. and Mandal, M. (2021) The Emerging Roles of Exosomes in Anti-Cancer Drug Resistance and Tumor Progression: An Insight towards Tumor-Microenvironment Interaction. Bio-chimica et Biophysica Acta (BBA)-Reviews on Cancer, 1875, Article ID: 188488. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yan, J., Zhang, N., Zhang, Z., et al. (2021) Redox-Responsive Polyethyleneimine/Tetrahedron DNA/Doxorubicin Nanocomplexes for Deep Cell/tissue Penetration to Overcome Multi-drug Resistance. Journal of Controlled Release, 329, 36-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Qin, S., Li, A., Yi, M., et al. (2019) Recent Advances on Anti-Angiogenesis Receptor Tyrosine Kinase Inhibitors in Cancer Therapy. Journal of Hematology & Oncology, 12, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Yang, J.C., Haworth, L., Sherry, R.M., et al. (2003) A Random-ized Trial of Bevacizumab, an Anti-Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer. New England Journal of Medicine, 349, 427-434. [Google Scholar] [CrossRef]
|
|
[10]
|
Huang, M., Lin, Y., Wang, C., et al. (2022) New Insights into Anti-angiogenic Therapy Resistance in Cancer: Mechanisms and Therapeutic Aspects. Drug Resistance Updates, 64, Article ID: 100849. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Xu, X.-X., Chen, S.-Y., Yi, N.-B., et al. (2022) Research Pro-gress on Tumor Hypoxia-Associative Nanomedicine. Journal of Controlled Release, 350, 829-840. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Aventaggiato, M., Barreca, F., Sansone, L., et al. (2022) Sirtuins and Hypoxia in EMT Control. Pharmaceuticals, 15, Article No. 737. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Tang, M., Bolderson, E., O’Byrne, K.J. and Richard, D.J. (2021) Tumor Hypoxia Drives Genomic Instability. Frontiers in Cell and Developmental Biology, 9, Article 626229. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Janssens, L.K. and Stove, C.P. (2021) Sensing an Oxygen Sensor: Development and Application of Activity-Based Assays Directly Monitoring HIF Heterodimerization. Analytical Chem-istry, 93, 14462-14470. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Gunaratnam, L. and Bonventre, J.V. (2009) HIF in Kidney Disease and Development. Journal of the American Society of Nephrology, 20, 1877-1887. [Google Scholar] [CrossRef]
|
|
[16]
|
Kaur, B., Khwaja, F.W., Severson, E.A., et al. (2005) Hypoxia and the Hypoxia-Inducible-Factor Pathway in Glioma Growth and Angiogenesis. Neuro-Oncology, 7, 134-153. [Google Scholar] [CrossRef]
|
|
[17]
|
Wicks, E.E. and Semenza, G.L. (2022) Hypoxia-Inducible Fac-tors: Cancer Progression and Clinical Translation. Journal of Clinical Investigation, 132, e159839. [Google Scholar] [CrossRef]
|
|
[18]
|
Bauer, D., Visca, H., Weerakkody, A., et al. (2022) PET Imaging of Acid-ic Tumor Environment with 89Zr-Labeled pHLIP Probes. Frontiers in Oncology, 12, Article 882541. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Abumanhal-Masarweh, H., Koren, L., Zinger, A., et al. (2019) So-dium Bicarbonate Nanoparticles Modulate the Tumor Ph and Enhance the Cellular Uptake of Doxorubicin. Journal of Controlled Release, 296, 1-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Calorini, L., Peppicelli, S. and Bianchini, F. (2012) Extracellular Acidity as Favouring Factor of Tumor Progression and Metastatic Dissemination. Experimental Oncology, 34, 79-84.
|
|
[21]
|
Végran, F., Boidot, R., Michiels, C., Sonveaux, P. and Feron, O. (2011) Lactate Influx through the Endo-thelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway that Drives Tumor Angiogenesis. Cancer Research, 71, 2550-2560. [Google Scholar] [CrossRef]
|
|
[22]
|
Chaussain, C., Boukpes-si, T., Khaddam, M., et al. (2013) Dentin Matrix Degradation by Host Matrix Metalloproteinases: Inhibition and Clinical Perspectives toward Regeneration. Frontiers in Physiology, 4, Article 308. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Zhen, Z., Tang, W., Wang, M., et al. (2017) Protein Nanocage Me-diated Fibroblast-Activation Protein Targeted Photoimmunotherapy to Enhance Cytotoxic T Cell Infiltration and Tumor Control. Nano Letters, 17, 862-869. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Madar, S., Goldstein, I. and Rotter, V. (2013) ‘Cancer Associat-ed Fibroblasts’—More than Meets the Eye. Trends in Molecular Medicine, 19, 447-453. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Luo, H., Tu, G., Liu, Z. and Liu, M. (2015) Cancer-Associated Fibroblasts: A Multifaceted Driver of Breast Cancer Progression. Cancer Letters, 361, 155-163. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Watnick, R.S. (2012) The Role of the Tumor Microenvironment in Regulating Angiogenesis. Cold Spring Harbor Perspectives in Medicine, 2, a006676. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Rizzolio, S., Giordano, S. and Corso, S. (2022) The Importance of Being CAFs (in Cancer Resistance to Targeted Therapies). Journal of Experimental & Clinical Cancer Research, 41, Article No. 319. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Wallace, J.A., Li, F., Balakrishnan, S., et al. (2013) Ets2 in Tu-mor Fibroblasts Promotes Angiogenesis in Breast Cancer. PLOS ONE, 8, e71533. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Wu, K., Lin, K., Li, X., et al. (2020) Redefining Tu-mor-Associated Macrophage Subpopulations and Functions in the Tumor Microenvironment. Frontiers in Immunology, 11, Article 1731. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Riabov, V., Gudima, A., Wang, N., et al. (2014) Role of Tumor Associated Macrophages in Tumor Angiogenesis and Lymphangiogenesis. Frontiers in Physiology, 5, Article 75. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Zhang, J., Gao, J., Cui, J., et al. (2022) Tu-mor-Associated Macrophages in Tumor Progression and the Role of Traditional Chinese Medicine in Regulating TAMs to Enhance Antitumor Effects. Frontiers in Immunology, 13, Article 1026898. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Wu, H., Xu, J.-B., He, Y.-L., et al. (2012) Tumor-Associated Macrophages Promote Angiogenesis and Lymphangiogenesis of Gastric Cancer. Journal of Surgical Oncology, 106, 462-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Missiaen, R., Mazzone, M. and Bergers, G. (2018) The Reciprocal Function and Regulation of Tumor Vessels and Immune Cells Offers New Therapeutic Opportunities in Cancer. Semi-nars in Cancer Biology, 52, 107-116. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Martin, J.D., Seano, G. and Jain, R.K. (2019) Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annual Review of Physiology, 81, 505-534. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Lee, W.S., Yang, H., Chon, H.J. and Kim, C. (2020) Combination of Anti-Angiogenic Therapy and Immune Checkpoint Blockade Normalizes Vascular-Immune Crosstalk to Potentiate Cancer Immunity. Experimental & Molecular Medicine, 52, 1475-1485. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Pezzuto, A. and Carico, E. (20180 Role of HIF-1 in Cancer Pro-gression: Novel Insights. A Review. Current Molecular Medicine, 18, 343-351.[CrossRef] [PubMed]
|
|
[37]
|
Jung, H.-J., Seo, I., Jha, B.K., et al. (2014) Minocy-cline Inhibits Angiogenesis in Vitro through the Translational Suppression of HIF-1α. Archives of Biochemistry and Bi-ophysics, 545, 74-82. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Gupta, B., Chiang, L., Chae, K. and Lee, D.-H. (2013) Phenethyl Isothiocyanate Inhibits Hypoxia-Induced Accumulation of HIF-1α and VEGF Expression in Human Glioma Cells. Food Chemistry, 141, 1841-1846. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Park, J.J., Hwang, S.J., Park, J.-H. and Lee, H.-J. (2015) Chlorogenic Acid Inhibits Hypoxia-Induced Angiogenesis via Down-Regulation of the HIF-1α/AKT Pathway. Cellular Oncology, 38, 111-118. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Cheng, X., Zhang, X., Cheng, W., et al. (2014) Tumor-Specific Delivery of Histidine-Rich Glycoprotein Suppresses Tumor Growth and Metastasis by Anti-angiogenesis and Vessel Normalization. Current Gene Therapy, 14, 75-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
David, J.M., Owens, T.A., Inge, L.J., Bremner, R.M. and Rajasekaran, A.K. (2014) Gramicidin A Blocks Tumor Growth and Angiogenesis through Inhibition of Hypox-ia-Inducible Factor in Renal Cell Carcinoma. Molecular Cancer Therapeutics, 13, 788-799. [Google Scholar] [CrossRef]
|
|
[42]
|
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., et al. (2018) MiRNAs Regulate the HIF Switch during Hypoxia: A Novel Therapeutic Target. Angiogenesis, 21, 183-202. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Ando, H., Ikeda, A., Tagami, M., et al. (2022) Oral Administra-tion of Sodium Bicarbonate Can Enhance the Therapeutic Outcome of Doxil® via Neutralizing the Acidic Tumor Micro-environment. Journal of Controlled Release, 350, 414-420. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Parks, S.K. and Pouysségur, J. (2017) Targeting pH Regulating Proteins for Cancer Therapy—Progress and Limitations. Seminars in Cancer Biology, 43, 66-73. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Wiedmann, R.M., von Schwarzenberg, K., Palamidessi, A., et al. (2012) The V-ATPase-Inhibitor Archazolid Abrogates Tumor Metastasis via Inhibition of Endocytic Activation of the Rho-GTPase Rac1. Cancer Research, 72, 5976- 5987. [Google Scholar] [CrossRef]
|
|
[46]
|
Rath, S., Liebl, J., Fürst, R., Vollmar, A.M. and Zahler, S. (2014) Regulation of Endothelial Signaling and Migration by V-ATPase. Angiogenesis, 17, 587-601. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Fliedner, S.M., Yang, C., Thompson, E., et al. (2015) Potential Therapeutic Target for Malignant Paragangliomas: ATP Synthase on the Surface of Paraganglioma Cells. American Journal of Cancer Research, 5, 1558-1570.
|
|
[48]
|
Zhou, X., Yan, T., Huang, C., et al. (2018) Melanoma Cell-Secreted Exosomal miR-155-5p Induce Proangiogenic Switch of Cancer-Associated Fibroblasts via SOCS1/JAK2/STAT3 Sig-naling Pathway. Journal of Experimental & Clinical Cancer Research, 37, Article No. 242. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Guan, J., Zhang, H., Wen, Z., et al. (2014) Retinoic Acid Inhibits Pancreatic Cancer Cell Migration and EMT through the Downregulation of IL-6 in Cancer Associated Fibroblast Cells. Cancer Letters, 345, 132-139 [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Crawford, Y., Kasman, I., Yu, L., et al. (2009) PDGF-C Medi-ates the Angiogenic and Tumorigenic Properties of Fibroblasts Associated with Tumors Refractory to Anti-VEGF Treatment. Cancer Cell, 15, 21-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Nagasaki, T., Hara, M., Nakanishi, H., et al. (2014) Interleukin-6 Released by Colon Cancer-Associated Fibroblasts Is Critical for Tumour Angiogenesis: Anti-Interleukin-6 Receptor An-tibody Suppressed Angiogenesis and Inhibited Tumour–Stroma Interaction. British Journal of Cancer, 110, 469-478. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Zhou, F., Wang, M., Luo, T., Qu, J. and Chen, W.R. (2021) Pho-to-Activated Chemo-Immunotherapy for Metastatic Cancer Using a Synergistic Graphene Nanosystem. Biomaterials, 265, Article ID: 120421. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Cirri, P. and Chiarugi, P. (2011) Cancer Associated Fibro-blasts: The Dark Side of the Coin. American Journal of Cancer Research, 1, 482-497.
|
|
[54]
|
Salmaninejad, A., Valilou, S.F., Soltani, A., et al. (2019) Tumor-Associated Macrophages: Role in Cancer Development and Therapeutic Implica-tions. Cellular Oncology, 42, 591-608. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Kioi, M., Vogel, H., Schultz, G., et al. (2010) Inhibition of Vasculogenesis, But Not Angiogenesis, Prevents the Recurrence of Glioblastoma after Irradiation in Mice. Journal of Clinical Investigation, 120, 694-705.
|
|
[56]
|
Fu, L.-Q., Du, W.-L., Cai, M.-H., et al. (2020) The Roles of Tumor-Associated Macrophages in Tumor Angiogenesis and Metastasis. Cellular Immunology, 353, Article ID: 104119. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Nakanishi, Y., Nakatsuji, M., Seno, H., et al. (2011) COX-2 i Inhibition Alters the Phenotype of Tumor-Associated Macrophages From M2 to M1 in ApcMin/+ Mouse Polyps. Carcinogenesis, 32, 1333-13339. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Liu, Y., Zhao, L., Li, D., et al. (2013) Microvesicle-Delivery miR-150 Promotes Tumorigenesis by up-Regulating VEGF, and the Neutralization of miR-150 Attenuate Tumor Development. Protein & Cell, 4, 932-941. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Huang, H. (2018) Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors, 18, Article No. 3249. [Google Scholar] [CrossRef] [PubMed]
|
|
[60]
|
Li, Z., Zheng, Z., Li, C., et al. (2020) Therapeutic Drugs and Drug Deliv-ery Systems Targeting Stromal Cells for Cancer Therapy: A Review. Journal of Drug Targeting, 28, 714-726. [Google Scholar] [CrossRef]
|
|
[61]
|
Guo, Y., Wang, D., Song, Q., et al. (2015) Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. ACS Nano, 9, 6918-6933. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Zhao, Y., Wang, H., Yang, Y., et al. (2020) Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant En-hances Antitumor Activity against Established Large TC-1 Grafted Tumors in Mice. International Journal of Nanomedi-cine, 15, 9571-9586. [Google Scholar] [CrossRef]
|
|
[63]
|
Chen, C.-A., Ho, C.-M., Chang, M.-C., et al. (2010) Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lympho-cytes and Inhibiting Tumor Angiogenesis. Molecular Therapy, 18, 1233- 1243. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Cao, M., Xu, Y., Youn, J.-I., et al. (2011) Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model. Laboratory Investigation, 91, 598-608. [Google Scholar] [CrossRef] [PubMed]
|